Skip to main content
SpringerLink
Log in
Book cover

The Pathobiology of Breast Cancer pp 79–110Cite as

The Invasive Breast Cancer Types

  • Chapter
  • First Online:

Abstract

Several morphologic and endocrinologic criteria are commonly used to classify breast tumors; these include histologic pattern, degree of nuclear pleomorphism, number of mitoses, presence of inflammatory response, blood vessel invasion, lymph node involvement and the presence of hormone receptors [1–25]. In this chapter we will describe the classical histological type for evaluation of primary breast cancer. This knowledge cannot be replaced by those obtained with the immuno-cytochemical or genomic classification, but by the contrary will help the readers to understand the heterogeneity of breast cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Aamdal S, Bormer O, Jorgensen O et al (1984) Estrogen receptor and long-term prognosis in breast cancer. Cancer 53:2525–2529

    Article  CAS  PubMed  Google Scholar 

  2. Antomiades K, Spector H (1979) Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Pathol 71:497–503

    Article  Google Scholar 

  3. Bishop HM, Blarney RW, Elston CW, Hoybittle JL, Nicholson RI, Griffiths K (1979) Relationship of estrogen-receptor status to survival in breast cancer. Lancet 1:283–284

    Article  Google Scholar 

  4. Black MM, Opler SR, Speer FD (1955) Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg Gynecol Obstet 100:543–551

    CAS  PubMed  Google Scholar 

  5. Black MM, Speer FD, Opler SR (1956) Structural representations of tumor-host relationships in mammary carcinoma. Biologic prognostic significance. Am J Clin Pathol 26:250–265

    Article  CAS  PubMed  Google Scholar 

  6. Black MM, Speer FD (1957) Nuclear’ structure in cancer tissues. Surg Gynecol Obstet 105:97–102

    CAS  PubMed  Google Scholar 

  7. Bloom HJG, Richardson WW (1957) Histologic grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cutler SJ, Black MM, Goldenberg IS (1963) Prognostic factor in cancer of the female breast. Cancer 16:1589–1597

    Article  Google Scholar 

  9. Cutler SJ, Black MM, Friedell GH, Vidone RA, Goldenberg IS (1966) Prognostic factors in cancer of the female breast. II, Reproductibility of histopathologic classification. Cancer 19:75–82

    Article  CAS  PubMed  Google Scholar 

  10. Fisher B, Slack NH (1970) Number of lymph nodes examined and the prognosis of breast cancer. Surg Gynecol Obstet 131:79–88

    CAS  PubMed  Google Scholar 

  11. Fisher ER, Gregorio RM, Fisher B (1975) The pathology of invasive breast cancer-a syllabus derivcd from findings of the National Surgical Adjuvant Breast Project (Protocol N. 4). Cancer 36:1–84

    Article  CAS  PubMed  Google Scholar 

  12. Fisher ER, Palekar AS, Redmond C, Barton N, Fisher B (1980) Pathologic findings from the National Surgical Adjuvant Breast Project. (Protocol N. 4). VI. Invasive papillary cancer. Am J Clin Pathol 73:313–322

    Article  CAS  PubMed  Google Scholar 

  13. Fisher ER, Redmond CK, Lieu H, Rockette H, Fisher B (1980) CoIlaborating NSABP Investigators: correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 45:349–353

    Article  CAS  PubMed  Google Scholar 

  14. Foote FW Jr (1959) Surgical pathology of cancer of the breast. In: Parsons WH (ed) Cancer of the breast. Charles C Thomas, Springfield, pp 37–38

    Google Scholar 

  15. Hahnel R, Wooding T, Vivian AB (1979) Prognostic value of estrogen receptor in primary breast cancer. Cancer 44:671–675

    Article  CAS  PubMed  Google Scholar 

  16. Knight WA, Livingston RB, Bregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669–4671

    CAS  PubMed  Google Scholar 

  17. Lane N, Gokiel H, Salerno RA, Haagensen CD (1961) Clinocopathologic analysis of the surgical curability of breast cancers: a minimum ten year study of a personal series. Am Surg 153:483–498

    CAS  Google Scholar 

  18. Masters JRW, Sangster K, Hawkins RA, Shivas AA (1976) Elastosis and estrogen receptors in human breast cancer. Br J Cancer 33:342–343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Maynard PV, Blaney RN, Elston CW, Haybittle JL, Griffiths K (1978) Oestrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res 38:4292–4295

    CAS  PubMed  Google Scholar 

  20. McDivitt RW, Stewart FW, Berg JW (1968) Tumors of the breast, Atlas of tumor pathology, second series. Armed Forces Institute of Patho!ogy, Washington, DC

    Google Scholar 

  21. McGuire WL (1975) Current status of estrogen receptors in human breast cancer. Cancer 36:638–644

    Article  CAS  PubMed  Google Scholar 

  22. Patchefsky A, Shaber GS, Schwartz GF, Feig SA, Norlinger RE (1977) The pathology of breast cancer detected by mass population screening. Cancer 40:1659–1670

    Article  CAS  PubMed  Google Scholar 

  23. Rich MA, Furmanski P, Brooks SC (1978) The Breast Cancer Prognostic Study Surgery and Pathology Associates: prognostic value of estrogen receptor. Cancer Res 38:4296–4298

    CAS  PubMed  Google Scholar 

  24. Rosen PP (1979) The pathological classification of human mammary carcinoma, Past, present and future. Ann Clin Lab Sci 144:156

    Google Scholar 

  25. Sanfilippo O, Daidone MG, DiFronzo G, Silvestrini R (1979) Short term tissue culture of human breast cancer. Cancer 43:2365–2369

    Article  CAS  PubMed  Google Scholar 

  26. Rosai J (2004) Breast. Chapter 20. In: Rosai and Ackerman’s surgical pathology. Mosby, New York, pp 1802–1818

    Google Scholar 

  27. Kuhajda FP, Offutt LE, Mendelsohn G (1983) The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications. Cancer 52:1257–1264

    Article  CAS  PubMed  Google Scholar 

  28. Loy TS, Chapman RK, Diaz-Arias AA, Bulatao IS, Bickel JT (1991) Distribution of BCA -225 in adenocarcinomas. An immunohistochemical study of 446 cases. Am J Clin Pathol 96:326–329

    Article  CAS  PubMed  Google Scholar 

  29. Prey MU, Bedrossian CW, Masood S (1991) The value of monoclonal antibody B72.3 for the diagnosis of breast carcinoma. Experience with the first commercially available source. Hum Pathol 22:598–602

    Article  CAS  PubMed  Google Scholar 

  30. Robertson JF, Ellis IO, Bell J, Todd JH, Robins A, Elston CW, Blarney RW (1989) Carcinoembryonic antigen immunocytochemistry in primary breast cancer. Cancer 64:1638–1645

    Article  CAS  PubMed  Google Scholar 

  31. Tavassoli FA, Jones MW, Majeste RM, Bratthauer GL, O’Leary TJ (1990) Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease. Am J Surg Pathol 14:128–133

    Article  CAS  PubMed  Google Scholar 

  32. Domagala W, Wozniak L, Lasota I, Weber K, Osborn M (1990) Vimentin is preferentially expressed in high-grade ductal and medullary but not in lobular breast carcinomas. Am J Pathol 137:J059–1064

    Google Scholar 

  33. Guerreiro Da Silva ID, Hu YF, Russo IH, Ao X, Salicioni AM, Yang X, Russo J (2000) S100P Ca+2-binding protein overexpression is associated with immortalization and neoplastic transformation of human breast epithelial cells in vitro and tumor progression in vivo. Int J Oncol 16:231–240

    CAS  PubMed  Google Scholar 

  34. Dwarakanath S, Lee AKC, DeLellis RA, Silverman ML, Frasca L, Wolfe HI (1987) S-100 protein positivity in breast carcinomas. A potential pitfall in diagnostic immunohistochemistry. Hum Pathol 18:1144–1148

    Article  CAS  PubMed  Google Scholar 

  35. Lunde S, Nesland JM, Holm R, Johannessen JV (1987) Breast carcinomas with protein 5-100 immunoreactivity. An immunocytochemical and ultrastructural study. Pathol Res Pract 182:627–631

    Article  CAS  PubMed  Google Scholar 

  36. Huang Y, Fernandez S, Goodwin S, Russo PA, Russo IH, Sutter T, Russo J (2007) Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17- beta- estradiol. Cancer Res 67:11147–11157

    Article  CAS  PubMed  Google Scholar 

  37. Russo J, Tait L, Russo IH (1986) Guidelines in the ultrastructural diagnosis of tumors. In: Russo J, Somers SC (eds) Tumor diagnosis by electron microscopy. Field, Rich and Associates, New York, pp 15–126

    Google Scholar 

  38. Page DL, Dixon JM, Anderson TJ, Lee D, Stewart HJ (1983) Invasive cribriform carcinoma of the breast. Histopathology 7:525–536

    Article  CAS  PubMed  Google Scholar 

  39. Venable JG, Schwartz AM, Silverberg SG (1990) Infiltrating cribriform carcinoma of the breast. A distinctive clinicopathologic entity. Hum Pathol 21:333–338

    Article  CAS  PubMed  Google Scholar 

  40. Walker RA (1982) Mucoid carcinomas of the breast. A study using mucin histochemistry and peanut lectin. Histopathology 6:571–579

    Article  CAS  PubMed  Google Scholar 

  41. Sáez C, Japón MA, Poveda MA, Segura DI (2001) Mucinous (colloid) adenocarcinomas secrete distinct O-acylated forms of sialomucins: a histochemical study of gastric, colorectal and breast adenocarcinomas. Histopathology 39:554–560

    Article  PubMed  Google Scholar 

  42. O’Connell JT, Shao ZM, Drori E, Basbaum CB, Barsky SH (1998) Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol 29:1517–1523

    Article  PubMed  Google Scholar 

  43. Norris HI, Taylor HE (1965) Prognosis of mucinous (gelatinous) carcinoma of the breast. Cancer 18:879–885

    Article  CAS  PubMed  Google Scholar 

  44. Rasmussen BB, Rose C, Christensen IB (1987) Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol 87:155–160

    Article  CAS  PubMed  Google Scholar 

  45. McDivitt RW, Boyce W, Gersell D (1982) Tubular carcinoma of the breast. Clinical and pathological observations concerning 135 cases. Am J Surg Pathol 6:401–411

    Article  CAS  PubMed  Google Scholar 

  46. Peters GN, Wolff YI, Haagensen CD (1981) Tubular carcinoma of the breast. Clinical pathologic correlations based on 100 cases. Ann Surg 193:138–149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Carstens PHB, Huvos AG, Foote FIN Jr, Ashikari R (1972) Tubular carcinoma of the breast. A clinicopathologic study of 35 cases. Am J Clin Pathol 58:231–238

    Article  CAS  PubMed  Google Scholar 

  48. Deos PH, Noris HJ (1982) Well-differentiated (tubular) carcinoma of the breast. A clinicopathologic study of 145 pure and mixed cases. Am J Clin Pathol 78:1–7

    Article  CAS  PubMed  Google Scholar 

  49. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM (1999) Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 17:1442–1448

    CAS  PubMed  Google Scholar 

  50. Bloom HJG, Richardson WW, Fields JR (1970) Host resistance and survival in carcinoma of breasts. A study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J 3:181–188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Richardson WW (1956) Medullary carcinoma of the breast. A distinctive tumour type with a relatively good prognosis following radical mastectomy. Br J Cancer 10:415–423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Abati AD, Kimmel M, Rosen PP (1990) Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 94:371–377

    Article  CAS  PubMed  Google Scholar 

  53. McDivitt RW, Stewart FW (1966) Breast carcinoma in children. JAMA 195:388–390

    Article  CAS  PubMed  Google Scholar 

  54. Rosen PP, Cranor ML (1991) Secretory carcinoma of the breast. Arch Pathol Lab Med 115:141–144

    CAS  PubMed  Google Scholar 

  55. Tavassoli FA, Norris HJ (1980) Secretory carcinoma of the breast. Cancer 45:2404–2413

    Article  CAS  PubMed  Google Scholar 

  56. Bussolati G, Papotti M, Sapino A, Gugliotta P, Ghiringhello B, Azzopard JG (1987) Endocrine markers in argyrophilic carcinomas of the breast. Am J Surg Pathol 11:248–256

    Article  CAS  PubMed  Google Scholar 

  57. Oberman HA (1987) Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 11:918–929

    Article  CAS  PubMed  Google Scholar 

  58. Paget J (1874) On disease of the mammary areola preceding cancer of the mammary gland. St Barth Hosp Rep 10:87–89

    Google Scholar 

  59. Acs G, Lawton TJ, Rebbeck TR, Li Volsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115:85–98

    Article  CAS  PubMed  Google Scholar 

  60. Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M (1993) Nuclear protein accumulates preferentially in medullary and highcgrade ductal but in lobular breast carcinomas. Am J Pathol 142:669–674

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM (2001) E-cadherin reactivity of 95 non-invasive ductal and lobular lesions of the breast implications for the interpretation of problematic lesions. Am J Clin Pathol 115:534–542

    Article  CAS  PubMed  Google Scholar 

  62. Lehr HA, Folpe A, Yaziji H, Kommoss F, Gown AM (2000) Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol 114:190–196

    Article  CAS  PubMed  Google Scholar 

  63. Weidner N, Semple JP (1992) Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 23:1167–1171

    Article  CAS  PubMed  Google Scholar 

  64. Frolik D, Caduff R, Varga Z (2001) Pleomorphic lobular carcinoma of the breast: its cell kinetics, of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classification infiltrating lobular carcinomas. Histopathology 39:503–513

    Article  CAS  PubMed  Google Scholar 

  65. Middleton LP, Palacios DM, Bryant BR, Krebs P, Otis CN, Merino MJ (2000) Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24:1650–1656

    Article  CAS  PubMed  Google Scholar 

  66. Radhi JM (2000) Immunohistochemical analysis of pleomorphic lobular carcinoma: Higher expression of p53 and chromogranin and lower expression of ER and PgR. Histopathology 36:156–160

    Article  CAS  PubMed  Google Scholar 

  67. Wahed A, Connelly J, Reese T (2002) E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann Diagn Pathol 6:349–351

    Article  PubMed  Google Scholar 

  68. Fisher ER, Gregorio RM, Redmond CI, Fisher B (1977) Tubulolobular invasive breast cancer. A variant of lobular invasive cancer. Hum Pathol 8:679–683

    Article  CAS  PubMed  Google Scholar 

  69. Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS (2000) Microinvasive breast carcinoma; clinicopathologic analysis of a single institution experience. Cancer 88:1403–1409

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fox Chase Cancer Center, Philadelphia, PA, USA

    Jose Russo

Authors
  1. Jose Russo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Russo, J. (2016). The Invasive Breast Cancer Types. In: The Pathobiology of Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-40815-6_4

Download citation

Publish with us

Policies and ethics

Search

Navigation